SCHEMBL19036732

SCHEMBL19036732

Nc1nccc(-c2ccc(Cl)c(Cl)c2)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 4/20 1.00
AURKA O14965 2/20 0.55
HSP90AA1 P07900 2/20 0.55
PRKACA P17612 1/20 0.55
ADORA2A P29274 1/20 0.55
DHFR P00374 1/20 0.54
RAB9A P51151 3/20 0.53
NPC1 O15118 2/20 0.53
CDK2 P24941 3/20 0.53
CHUK O15111 1/20 0.53
PDPK1 O15530 1/20 0.53
RPS6KB1 P23443 1/20 0.53
KDR P35968 1/20 0.53
TGFBR1 P36897 1/20 0.53
SYK P43405 1/20 0.53
JAK3 P52333 1/20 0.53
ROCK1 Q13464 1/20 0.53
AURKB Q96GD4 1/20 0.53
MAP3K5 Q99683 1/20 0.53
PIK3CA P42336 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22641600 0.85 KMO (0.73) KMOAURKAHSP90AA1PRKACAADORA2A
SCHEMBL22641581 0.85 KMO (0.73) KMOAURKAHSP90AA1PRKACAADORA2A
SCHEMBL22397784 0.85 KMO (0.73) KMOAURKAHSP90AA1PRKACAADORA2A
SCHEMBL7544652 0.81 KMO (0.69) KMORAB9ANPC1PIK3CAPIK3CB
SCHEMBL15889280 0.81 KMO (0.68) KMOAURKAHSP90AA1PRKACAADORA2A
SCHEMBL15889299 0.81 KMO (0.68) KMOAURKAHSP90AA1PRKACAADORA2A
SCHEMBL27796038 0.80 KMO (0.67) KMOAURKAHSP90AA1PRKACAADORA2A
SCHEMBL3412705 0.79 KMO (0.66) KMOAURKAHSP90AA1PRKACAADORA2A
SCHEMBL2402821 0.79 KMO (0.65) KMORAB9ANPC1PIK3CAPIK3CB
SCHEMBL28320772 0.76 KMO (0.61) KMORAB9ANPC1PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 EP disclosed